FindTrial
Sign In

To measure biological markers in blood and urine sample of preterm babies

Systemic biomarkers of retinopathy of prematurity in preterm babies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/10/021769
Enrollment
70
Registered
2019-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H351- Retinopathy of prematurity

Interventions

None listed

Sponsors

Government medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group A include Neonates with Type 1 ROP Group B include Neonates without any ROP matched by gestation within 1 week for neonates enrolled in group A

Exclusion criteria

Exclusion criteria: Infants with Congenital abnormalities Infants born to mother with gestational metabolic diseases TORCH infections suspicion on eye examination Hydrocephalus Necrotising enterocolitis Periventricular leukomalacia

Design outcomes

Primary

MeasureTime frame
To compare inflammatory (Interleukin-6 and Interleukin-8) and angiogenic (Vascular endothelial growth factor) biomarkers in preterm babies with or without Type 1 Retinopathy of prematurity To study the association of systemic biomarkers with the stage and zone of Retinopathy of prematurity Timepoint: AT 18 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Parrina Sehgal

Government medical college and hospital chandigarh

subina_navya@yahoo.com9646121587

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026